Investigate / reported ownership
HCA
Hca Healthcare Inc
6 tracked reported owners · snapshot updated 2026-10-04. Delayed disclosures, not live holdings or an investment recommendation.
Who reports owning HCA?
Select a manager to inspect their portfolio. Reports may cover different quarters; portfolio weights describe disclosed long 13F holdings, not total economic exposure.
| #↑ | Manager | % Port. | History | Value | Shares |
|---|---|---|---|---|---|
| 1 | First Eagle Investment Management | 2.1% | 33q | $1.28B | 3,295,565 |
| 2 | Joel Greenblatt | <0.1% | 35q | $72M | 184,460 |
| 3 | Bill Nygren | 0.1% | 40q | $60M | 154,097 |
| 4 | Richard Pzena | 0.1% | 6q | $38M | 96,598 |
| 5 | Thomas Gayner | 0.3% | 12q | $33M | 84,366 |
Go beyond ownership.
HCA operates acute-care, behavioral and rehabilitation hospitals, ambulatory surgery centers and endoscopy centers.
Question to investigate: Can HCA's local hospital networks and scale keep supporting its operations while it carries heavy debt obligations?
Company research reviewed 2026-10-03; a dated source-linked starting point, not the investors’ stated reasons.
Understand the business and investment case →Filing dates and original SEC sources
Reported position changes
Net disclosed share changes—not individual trades or execution dates. NEW has no prior-position percentage comparison; EXIT weight refers to the previous report.
| Manager | Move | % Port. | Δ Shares | Value | Filed |
|---|---|---|---|---|---|
| Glenn Greenberg | ADD | <0.1% | +263% | $2M | Aug 14, 2026 |
Keep your next step small.
Save the company and inspect its evidence. Recording a private view is optional and requires a separate, explicit save.
Record my own view →Optional email follow
Latticework Follow
Follow HCA
Email me only when a reviewed weekly edition contains a material new decision about HCA: a new position, exit, or a large share-count change that also clears the size threshold. There may be quiet weeks.
Confirm by email. Manage or stop follows in one click. See our privacy notice.
Long US 13F disclosures omit shorts and can be amended. CUSIP 40412C101. No current price, valuation or manager motive is inferred.